Dark Side of Cancer Therapy: Cancer Treatment-Induced Cardiopulmonary Inflammation, Fibrosis, and Immune Modulation
Advancements in cancer therapy increased the cancer free survival rates and reduced the malignant related deaths. Therapeutic options for patients with thoracic cancers include surgical intervention and the application of chemotherapy with ionizing radiation. Despite these advances, cancer therapy-r...
Main Authors: | Ettickan Boopathi, Chellappagounder Thangavel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/18/10126 |
Similar Items
-
Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature
by: N. V. Marinichenko, et al.
Published: (2019-06-01) -
Editorial: Cardiac Fibrosis, From Lineage Tracing to Therapeutic Application
by: Claudio de Lucia, et al.
Published: (2021-01-01) -
The Dynamic Interplay Between Cardiac Inflammation and Fibrosis
by: Toby P. Thomas, et al.
Published: (2020-09-01) -
PARK7 Protects Against Chronic Kidney Injury and Renal Fibrosis by Inducing SOD2 to Reduce Oxidative Stress
by: Lijun Yin, et al.
Published: (2021-05-01) -
Hyperphosphatemia-Induced Oxidant/Antioxidant Imbalance Impairs Vascular Relaxation and Induces Inflammation and Fibrosis in Old Mice
by: Ana Asenjo-Bueno, et al.
Published: (2021-08-01)